Foxo Technologies Inc (FOXO)

[Fire_starter]

🔥🔥ATOMIC BOMB NEWS IS COMING🔥🔥🔥

Patent No. 11,817,214 titled "Machine Learning Model Trained to Determine a Biochemical State and/or Medical Condition Using DNA Epigenetic Data

FOXO" can refer to the company FOXO Technologies Inc., which focuses on commercializing epigenetic technology, particularly using saliva-based biomarkers and AI to provide health, lifestyle, and longevity insights. This can also relate to the scientific research on the role of the FoxO family of transcription factors, which are involved in cellular processes like aging, autophagy, and stress response.
In a scientific context: the FoxO protein family
The FoxO family of proteins are transcription factors that play a crucial role in regulating cellular functions and are implicated in aging and longevity.
Research has shown that FoxO proteins can promote autophagy (a cellular clean-up process).
They are also involved in regulating genes that degrade damaged proteins through the proteasome.
Studies have explored the role of FoxO proteins in other conditions, such as investigating sex-specific epigenetic changes in the context of autism spectrum disorder, according to the National Institutes of Health.
In a commercial context: FOXO Technologies Inc.
FOXO Technologies Inc. is a company that uses AI and machine learning to develop epigenetic biomarkers, primarily from saliva samples.
The company has a patent for machine learning models that analyze this epigenetic data to provide insights into a person's health, lifestyle, and longevity.
FOXO is applying this technology to the life insurance industry for a more simplified underwriting process.
The company has announced plans to spin off its epigenetics subsidiary, FOXO Labs, which will focus on a direct-to-consumer, subscription-based model for personalized health and longevity coaching.
This spin-off will leverage the epigenetic biomarkers along with AI and wearable data to provide personalized wellness guidance.

https://www.stocktitan.net/news/FOXO/foxo-technologies-inc-announces-intention-to-spin-off-epigenetics-f7l78r3sq91t.html